510(k) Report

De Novo · Granted

Granted

AeroForm Tissue Expander System

DEN150055De NovoGranted Dec 21, 2016380-day reviewClass II21 CFR 878.3510

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Airxpanders, Inc. · PQN Carbon Dioxide Gas Controlled Tissue Expander

Granted on Dec 21, 2016 as a new device type through De Novo after a 380-day review. 2 later devices descend from it.

Decided
Dec 21, 2016
Review
380 days
Class
Class II
Product code
PQN
Recalls
None

2 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2017: 1 descendant cleared2019: 1 descendant cleared201620182020202220242026
  1. This deviceDEN150055 AeroForm Tissue Expander SystemAirxpanders, Inc. · 2016
  2. Descendant · cites it directly · 1 of its ownK170075 AeroForm Tissue Expander (v3.0), AeroForm Dosage Controller (v1.5)Airxpanders, Inc. · 2017
  3. Descendant · 2 generations on · 0 of its ownK191138 AeroForm Tissue Expander, SmoothAirxpanders, Inc. · 2019

Most influential descendants

Showing 2 of 2 · See all
  • K170075AeroForm Tissue Expander (v3.0), AeroForm Dosage Controller (v1.5)Airxpanders, Inc. · 2017 · cites it directly1descendant
  • K191138AeroForm Tissue Expander, SmoothAirxpanders, Inc. · 2019 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)DEN150055AeroForm Tissue Expander SystemAirxpanders, Inc.2016—
+1K170075AeroForm Tissue Expander (v3.0), AeroForm Dosage Controller (v1.5)Airxpanders, Inc.2017—
+2K191138AeroForm Tissue Expander, SmoothAirxpanders, Inc.2019—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201710
201910
FIG. 1 — Lineage of DEN150055, 2016–2019Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA De Novo database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in PQN? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

Does it have a predicate?

De Novo decisions do not claim a predicate device.

What descends from it? (2)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K170075AeroForm Tissue Expander (v3.0), AeroForm Dosage Controller (v1.5)Airxpanders, Inc.20171

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K170075 (Airxpanders, Inc., 2017) has gone furthest, with 1 descendant of its own.

How does its category compare?

All PQN devices

PQN Carbon Dioxide Gas Controlled Tissue Expander: FDA decisions, review times, recalls and adverse event reports over 20 years. 2016, this device’s year, is highlighted.

FDA decisions per year · PQN

1in 2019

2016: 12017: 12019: 1
2007high 1 (2016) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · PQN

Too few PQN 510(k)s in any year since 2007 to give a median.

Recalls per year · PQN

No recall names PQN since 2007.

Adverse event reports per year · PQN

1in 2018

2017: 12018: 1
2007high 1 (2017) · low 0 (2007)2025

MAUDE reports naming product code PQN, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20161—00
20171—01
20180—01
20191—00
20200—00
20210—00
20220—00
20230—00
20240—00
20250—00
20260—0—

What is it indicated for?

The AeroForm Tissue Expander System is used for soft tissue expansion in breast reconstruction following mastectomy, for the treatment of underdeveloped breasts, and for the treatment of soft tissue deformities in the breast.

The AeroForm Expander is intended for temporary subcutaneous or submuscular implantation and is not intended for use beyond six months.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “DEN150055: AeroForm Tissue Expander System.” Lineage record from FDA De Novo data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/DEN150055

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026